Study Links Low Testosterone Levels to Increased Risk of Premature Death in Men

A recent study suggests that testosterone levels could serve as a significant indicator of longevity in men. Conducted on a sample of 24,109 men worldwide, the research found a correlation between low testosterone levels and a higher likelihood of early mortality. Published in the Annals of Internal Medicine, the study compared baseline testosterone levels with health outcomes, drawing data from previous research involving older men, typically ranging from late 40s to mid-70s.

The analysis revealed that men with a baseline testosterone level below 213 nanograms per deciliter (ng/dL) faced an elevated risk of premature death from any cause. Notably, healthy testosterone levels typically range from 260 to 900 ng/dL depending on age. Moreover, men with notably low testosterone levels (below 153 ng/dL) demonstrated a heightened risk of mortality from cardiovascular disease.

While the findings underscore the potential significance of testosterone in health and longevity, it’s essential to note that the study presents observational data, indicating a pattern rather than causation. Nonetheless, the research contributes to understanding the complex relationship between testosterone levels and lifespan, particularly regarding hormone therapy for low testosterone.

The study focused on endogenous testosterone, the naturally occurring hormone in the body, rather than hormone therapy. However, insights into how testosterone influences longevity could impact the burgeoning hormone therapy market, where various products and services are advertised to address age-related declines in testosterone